Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

BUY
$0.8 - $2.85 $26,876 - $95,745
33,595 Added 112.8%
63,378 $165,000
Q4 2020

Feb 11, 2021

BUY
$0.69 - $0.9 $773 - $1,008
1,121 Added 3.91%
29,783 $22,000
Q3 2020

Nov 16, 2020

BUY
$0.72 - $1.04 $9,253 - $13,366
12,852 Added 81.29%
28,662 $21,000
Q1 2019

May 13, 2019

BUY
$1.65 - $3.29 $3,130 - $6,241
1,897 Added 13.63%
15,810 $26,000
Q4 2018

Feb 12, 2019

BUY
$1.5 - $5.4 $20,869 - $75,130
13,913 New
13,913 $21,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $311M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.